Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Researchers present novel radiomitigating compounds

Nov. 28, 2014

PRO-028 and PRO-027: novel NAC analogues for cocaine addiction

Nov. 26, 2014

RGFP-966, an epigenetic HDAC3 inhibitor, tested in a rat cocaine-abuse model

Nov. 17, 2014

Eisai and Arena report phase II data for lorcaserin in smoking cessation

Nov. 4, 2014

Orexo applies to FDA to expand Zubsolv label to include initiation of opioid dependence therapy

Oct. 13, 2014

Japanese approval for fomepizole to treat ethylene glycol and methanol poisonings

Sep. 26, 2014

Soligenix awarded NIAID contract to develop heat stable RiVax vaccine

Sep. 23, 2014

Legalon Sil given FDA orphan designation for amatoxin poisoning

Sep. 22, 2014

Cellerant's development of CLT-008 supported by additional government funding

Sep. 17, 2014

NIAAA to study gabapentin enacarbil for the treatment of alcohol use disorder

Sep. 12, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...